Pathstone Family Office’s LeonaBio Inc LONA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$859K Hold
42,549
0.01% 790
2023
Q2
$1.26M Hold
42,549
0.02% 415
2023
Q1
$1.06M Sell
42,549
-139,005
-77% -$4.48M 0.02% 424
2022
Q4
$4.09M Hold
181,554
0.07% 183
2022
Q3
$5.39M Buy
181,554
+12,670
+8% +$437K 0.1% 125
2022
Q2
$5.15M Buy
168,884
+5,930
+4% +$543K 0.11% 101
2022
Q1
$22M Buy
162,954
+18,729
+13% +$1.97M 0.51% 34
2021
Q4
$18.8M Buy
144,225
+29,580
+26% +$3.74M 0.47% 36
2021
Q3
$10.8M Buy
114,645
+48,484
+73% +$4.94M 0.31% 43
2021
Q2
$6.78M Buy
66,161
+16,219
+32% +$2.83M 0.2% 65
2021
Q1
$9.19M Buy
49,942
+41,754
+510% +$9.2M 0.31% 49
2020
Q4
$2.8M Sell
8,188
-282
-3% -$66.5K 0.12% 72
2020
Q3
$1.56M Buy
+8,470
New +$1.41M 0.17% 67

Other funds holding LONA

Pathstone Family Office's LONA Position: Q3 2023 in Review

Pathstone Family Office held its LeonaBio Inc (LONA) position steady in Q3 2023 at 42,549 shares worth $859K. The position accounts for 0.01% of the portfolio, ranked #790.

Pathstone Family Office first reported a position in LONA in Q3 2020 and has held it in 13 quarters since. The position peaked at $22M in Q1 2022. 70 funds tracked by Wall St. Rank hold LONA as of Q3 2023.

  • Pathstone Family Office held 42,549 shares of LeonaBio Inc worth $859K as of Q3 2023.
  • Pathstone Family Office left its LeonaBio Inc share count unchanged in Q3 2023.
  • LeonaBio Inc made up 0.01% of Pathstone Family Office's portfolio in Q3 2023, its #790 holding.
  • Pathstone Family Office first reported a position in LeonaBio Inc in Q3 2020 and has held it in 13 quarters since.
  • Pathstone Family Office's LeonaBio Inc position peaked at $22M in Q1 2022.
  • 70 funds tracked by Wall St. Rank held LeonaBio Inc as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.